101 related articles for article (PubMed ID: 12209032)
1. Serum concentrations of cartilage oligomeric matrix protein, fibrinogen and hyaluronan distinguish inflammation and cartilage destruction in experimental arthritis in rats.
Larsson E; Erlandsson Harris H; Lorentzen JC; Larsson A; Månsson B; Klareskog L; Saxne T
Rheumatology (Oxford); 2002 Sep; 41(9):996-1000. PubMed ID: 12209032
[TBL] [Abstract][Full Text] [Related]
2. Corticosteroid treatment of experimental arthritis retards cartilage destruction as determined by histology and serum COMP.
Larsson E; Erlandsson Harris H; Larsson A; Månsson B; Saxne T; Klareskog L
Rheumatology (Oxford); 2004 Apr; 43(4):428-34. PubMed ID: 15024132
[TBL] [Abstract][Full Text] [Related]
3. Increased serum levels of cartilage oligomeric matrix protein in chronic erosive arthritis in rats.
Vingsbo-Lundberg C; Saxne T; Olsson H; Holmdahl R
Arthritis Rheum; 1998 Mar; 41(3):544-50. PubMed ID: 9506583
[TBL] [Abstract][Full Text] [Related]
4. [Inhibition of cartilage destruction in collagen-induced arthritis by altered CII 263-272 peptide: experiment with rats].
Yao ZQ; Zhao JX; Li R; Li ZG
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3055-8. PubMed ID: 17288836
[TBL] [Abstract][Full Text] [Related]
5. Cartilage oligomeric matrix protein deficiency promotes early onset and the chronic development of collagen-induced arthritis.
Geng H; Carlsen S; Nandakumar KS; Holmdahl R; Aspberg A; Oldberg A; Mattsson R
Arthritis Res Ther; 2008; 10(6):R134. PubMed ID: 19014566
[TBL] [Abstract][Full Text] [Related]
6. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
Joosten LA; Helsen MM; Saxne T; van De Loo FA; Heinegard D; van Den Berg WB
J Immunol; 1999 Nov; 163(9):5049-55. PubMed ID: 10528210
[TBL] [Abstract][Full Text] [Related]
7. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
8. Increased serum levels of cartilage oligomeric matrix protein and bone sialoprotein in rats with collagen arthritis.
Larsson E; Müssener A; Heinegård D; Klareskog L; Saxne T
Br J Rheumatol; 1997 Dec; 36(12):1258-61. PubMed ID: 9448585
[TBL] [Abstract][Full Text] [Related]
9. CNI-1493, an inhibitor of proinflammatory cytokines, retards cartilage destruction in rats with collagen induced arthritis.
Larsson E; Harris HE; Palmblad K; Månsson B; Saxne T; Klareskog L
Ann Rheum Dis; 2005 Mar; 64(3):494-6. PubMed ID: 15708902
[TBL] [Abstract][Full Text] [Related]
10. Tissue-derived macromolecules and markers of inflammation in serum in early rheumatoid arthritis: relationship to development of joint destruction in hands and feet.
Fex E; Eberhardt K; Saxne T
Br J Rheumatol; 1997 Nov; 36(11):1161-5. PubMed ID: 9402859
[TBL] [Abstract][Full Text] [Related]
11. Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis.
Vilím V; Vytásek R; Olejárová M; Machácek S; Gatterová J; Procházka B; Kraus VB; Pavelka K
Osteoarthritis Cartilage; 2001 Oct; 9(7):612-8. PubMed ID: 11597173
[TBL] [Abstract][Full Text] [Related]
12. Extra-articular cartilage affected in collagen-induced, but not pristane-induced, arthritis models.
Hansson AS; Lu S; Holmdahl R
Clin Exp Immunol; 2002 Jan; 127(1):37-42. PubMed ID: 11882030
[TBL] [Abstract][Full Text] [Related]
13. Cartilage oligomeric matrix protein (COMP) is modified by intra-articular liposomal clodronate in an experimental model of arthritis.
Gomez-Barrena E; Lindroos L; Ceponis A; López-Franco M; Sanchez-Pernaute O; Mönkkönen J; Salo J; Herrero-Beaumont G; Konttinen Y
Clin Exp Rheumatol; 2006; 24(6):622-8. PubMed ID: 17207376
[TBL] [Abstract][Full Text] [Related]
14. Cartilage oligomeric matrix protein (COMP)-induced arthritis in rats.
Carlsén S; Hansson AS; Olsson H; Heinegård D; Holmdahl R
Clin Exp Immunol; 1998 Dec; 114(3):477-84. PubMed ID: 9844060
[TBL] [Abstract][Full Text] [Related]
15. Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism.
Månsson B; Carey D; Alini M; Ionescu M; Rosenberg LC; Poole AR; Heinegård D; Saxne T
J Clin Invest; 1995 Mar; 95(3):1071-7. PubMed ID: 7533784
[TBL] [Abstract][Full Text] [Related]
16. Arthritis induced with minor cartilage proteins.
Carlsen S; Lu S; Holmdahl R
Methods Mol Med; 2007; 136():225-42. PubMed ID: 17983152
[TBL] [Abstract][Full Text] [Related]
17. Changes of cartilage and bone markers after intra-articular glucocorticoid treatment with and without postinjection rest in patients with rheumatoid arthritis.
Weitoft T; Larsson A; Saxne T; Rönnblom L
Ann Rheum Dis; 2005 Dec; 64(12):1750-3. PubMed ID: 15843449
[TBL] [Abstract][Full Text] [Related]
18. A relationship between mechanically-induced changes in serum cartilage oligomeric matrix protein (COMP) and changes in cartilage thickness after 5 years.
Erhart-Hledik JC; Favre J; Asay JL; Smith RL; Giori NJ; Mündermann A; Andriacchi TP
Osteoarthritis Cartilage; 2012 Nov; 20(11):1309-15. PubMed ID: 22868052
[TBL] [Abstract][Full Text] [Related]
19. Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation in early rheumatoid arthritis. A prospective 5-year study.
Roux-Lombard P; Eberhardt K; Saxne T; Dayer JM; Wollheim FA
Rheumatology (Oxford); 2001 May; 40(5):544-51. PubMed ID: 11371663
[TBL] [Abstract][Full Text] [Related]
20. Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis.
Wisłowska M; Jabłońska B
Clin Rheumatol; 2005 Jun; 24(3):278-84. PubMed ID: 15940561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
